BACKGROUND Despite the high rates of HIV control achieved by current antiretroviral therapy, HIV/HCV co-infection still has an unfavorable influence on the natural history of HCV, resulting in an increased rate of progression to cirrhosis, HCC and end stage liver disease. Although direct acting antivirals have...